| | | | | | | |
 | MODERNA, INC. | -3.93% | -5.86% | -8.51% | 7.19% | 607.14% | 65 718 |
 | LONZA GROUP AG | 0.83% | 6.43% | 23.06% | -10.44% | 38.50% | 44 419 |
| IQVIA HOLDINGS INC. | -0.14% | 2.80% | 14.94% | -4.79% | 50.01% | 43 805 |
| ALNYLAM PHARMACEUTICALS, INC. | -1.45% | -0.56% | -8.37% | 47.49% | 73.53% | 27 183 |
| SEAGEN INC. | -0.40% | -1.46% | 6.52% | -2.21% | 16.59% | 25 518 |
| ICON PUBLIC LIMITED COMPANY | -1.29% | 4.85% | 22.93% | -12.28% | 41.37% | 19 751 |
 | CELLTRION, INC. | 0.36% | -1.42% | 4.05% | 10.62% | 5.36% | 18 915 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | 2.13% | -2.29% | 11.34% | 11.46% | 45.87% | 14 063 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.06% | 2.98% | 18.33% | -23.50% | 65.29% | 12 854 |
| BIO-TECHNE CORPORATION | -1.84% | -3.95% | -7.09% | -25.49% | 53.19% | 12 313 |
| PHARMARON BEIJING CO., LTD. | 0.24% | -6.42% | 4.59% | -11.97% | 92.74% | 11 730 |
| UNITED THERAPEUTICS CORPORATION | -1.13% | -2.86% | -9.10% | 26.61% | 151.46% | 11 652 |
| QIAGEN N.V. | -0.86% | 1.00% | -1.00% | 0.30% | 39.15% | 11 339 |
| MEDPACE HOLDINGS, INC. | -0.48% | 7.83% | 9.98% | 32.63% | 150.72% | 7 281 |
 | GENSCRIPT BIOTECH CORPORATION | 0.78% | -3.59% | 3.42% | -3.38% | 34.84% | 6 875 |
| | | | | | | |
| | Moyenne | -0.34% | -0.17% | 5.67% | 2.82% | 97.72% | |
| | Moyenne pondérée par Capi. | -0.84% | -0.20% | 5.78% | 2.77% | 161.70% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
